Stent or Bypass?

In the final analysis of this important international study, most outcomes were better with CABG than with PCI in patients with at least moderately severe left main or three-vessel disease.

Responsive image

In the SYNTAX trial, investigators compared percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in patients with left main or three-vessel coronary artery disease. The previously reported 1-year results showed similar rates of death and myocardial infarction (MI) with both procedures, more strokes with CABG, and more repeat revascularization procedures with PCI. The SYNTAX investigators now present their final results after 5 years of follow-up.

Of 1800 patients randomized, 90% of those assigned to CABG and 97% of those assigned to PCI completed 5-year follow-up. The overall adverse-event rate was lower with CABG (27%) than with PCI (37%; P<0.001). However, neither all-cause mortality nor stroke rate differed significantly between the two groups. The rates of MI and repeat revascularization were higher with PCI than with CABG (9.7% vs. 3.8% and 26% vs. 14%, respectively). The between-group differences increased with greater anatomical disease complexity and reached significance in the intermediate-risk category (SYNTAX score, 23–32), although the difference in mortality was nonsignificant in this group. In patients with SYNTAX scores ≥33, the overall adverse-event rate was 27% with CABG and 44% with PCI, including a statistically significant absolute increase in all-cause mortality of about 8% with PCI.

Dr. Aybek's comment

These results confirm and extend the earlier findings from this landmark trial. As in the previous reports, outcomes were similar with coronary artery bypass grafting and percutaneous coronary intervention in the lowest tertile of SYNTAX score, whereas CABG outcomes were superior in the highest tertile. Longer follow-up now suggests that CABG beats PCI in the intermediate-risk group as well. However, this conclusion is likely to be controversial, because the benefit was driven primarily by repeat revascularizations and myocardial infarction. Patient preference for PCI will also influence decisions in these patients.


1. Mohr FW et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013 Feb 23; 381:629. (

2. Taggart DP. CABG or stents in coronary artery disease: End of the debate? Lancet 2013 Feb 23; 381:605. (

Prof. Dr. Tayfun Aybek

Cardiovascular Surgery

Mobile: +90 534 520 5317
Landline: +903122929891
Fax: +90 312 284 5870

TOBB ETÜ Hastanesi, Yaşam Caddesi No:5 Söğütözü 06510 Ankara

Life Energy and Biological Age Measurement

When we are not ill, we say we are “healthy”, but actually, is it true? Can we measure how healthy we are? Do we know what is inside of us, in our organs, thoughts or how we are affected by the environment and the things happening around us? How can we measure this? What do the signals coming from our body through 10 grams of a tiny chip can tell about us?

2579 Times viewed

N-butyl cyanoacrylate (NBCA) – Varicose vein surgery with gl...

This method uses local anesthesia rather than general anesthesia which provides a new varicose vein surgery method for the patients. Patients begin to walk and discharge from the hospital 15 minutes and continue their daily lives a day after this surgery.

2157 Times viewed